DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for CASI Pharmaceuticals, Inc. (CASI)
« Back to company indexCASI Chatter Timeline
Stock Ticker for CASI
Most Active Tweeters for CASI
| User | Tweets |
|---|---|
| @ConsumerFeed | 2 |
| @BlueBioNow | 2 |
| @gcassidy718 | 2 |
| @dispatchtribune | 2 |
| @dailypoliticaln | 2 |
Recent Tweets for CASI
 |
@BlueBioNow Instinct is telling me $CASI is going down to $2.88. https://t.co/LTzgM8iLYu 10:01am |
 |
@gcassidy718 $CASI damn if we pass $2.88 -2.14 % change recently https://t.co/W6REGbUBhi January 19th 2020, 5:01am |
 |
@ConsumerFeed CASI Pharmaceuticals $CASI Upgraded to “Sell” by BidaskClub https://t.co/Y6OgUonoUg January 18th 2020, 10:01am |
 |
@dailypoliticaln CASI Pharmaceuticals $CASI Lifted to “Sell” at BidaskClub https://t.co/WDItXGv24P January 18th 2020, 10:01am |
|
@BlueBioNow $CASI "Everything is impossible until someone does it" -2.29 % change recently https://t.co/LTzgM8iLYu January 18th 2020, 12:01am |
|
@ConsumerFeed Zacks: CASI Pharmaceuticals Inc $CASI Receives Average Rating of “Strong Buy” from Analysts https://t.co/6nLqQ5Okye January 16th 2020, 11:01pm |
|
@dailypoliticaln Zacks: CASI Pharmaceuticals Inc $CASI Given Average Rating of “Strong Buy” by Analysts https://t.co/cyXlY5KhLi January 16th 2020, 11:01pm |
 |
@dispatchtribune CASI Pharmaceuticals $CASI Upgraded to Sell by BidaskClub https://t.co/zIYkifSnZq January 16th 2020, 1:01pm |
 |
@WatchlistN CASI Pharmaceuticals $CASI Upgraded to Sell by BidaskClub https://t.co/8oNcewHMNF January 16th 2020, 1:01pm |
 |
@Gambiste1 RT @LoncarFunds: $CASI Chairman Wei-Wu He talks China biotech https://t.co/kgHrrVz54t https://t.co/c37NuxXGad January 16th 2020, 5:01am |
 |
@LoncarFunds $CASI Chairman Wei-Wu He talks China biotech https://t.co/kgHrrVz54t https://t.co/c37NuxXGad January 16th 2020, 4:01am |
 |
@SeekingAlpha $CASI - CASI Pharmaceuticals (CASI) Investor Presentation - Slideshow. Get more updates here:… https://t.co/lQr6wrNCVO January 15th 2020, 2:01pm |
 |
@EnterpriseLeade CASI Pharmaceuticals $CASI Upgraded by BidaskClub to “Sell” https://t.co/Iw2DFJ1M4V January 15th 2020, 2:01am |
 |
@OlympiaReport CASI Pharmaceuticals Inc $CASI Receives Average Recommendation of “Strong Buy” from Brokerages https://t.co/ht7D7vvc1Y January 14th 2020, 7:01pm |
|
@dispatchtribune CASI Pharmaceuticals Inc $CASI Given Consensus Recommendation of “Strong Buy” by Analysts https://t.co/JhHiD4swsv January 14th 2020, 6:01pm |
|
@gcassidy718 $CASI Enjoy the weekend everyone! Cheers! ???? 3.02 % change recently https://t.co/W6REGbUBhi January 14th 2020, 2:01pm |
 |
@bbnsnews Zacks: CASI Pharmaceuticals Inc $CASI Given $7.59 Average Price Target by Brokerages https://t.co/GbWQFJUCNj January 12th 2020, 11:01am |
 |
@ThisLincolnian Analysts Set $7.59 Price Target for CASI Pharmaceuticals Inc $CASI https://t.co/MvRT5tdO5V January 9th 2020, 1:01am |
 |
@AmericanBanking Analysts Set $7.59 Price Target for CASI Pharmaceuticals Inc $CASI https://t.co/yAPcEFxQ0R #stocks January 9th 2020, 1:01am |
 |
@ResearchPool $CASI #CASI Pharmaceuticals ... InsiderInsights Daily Ratings Report: January 6, 2020: InsiderInsights Ratings of C… https://t.co/DwIfxpLHpr January 7th 2020, 6:01am |
 |
@thisisDyuuz RT @Taylor8xeno8: $CASI bot shares for a more patient play to move higher. $8 test will be key to see if it can broke topside of coil. January 6th 2020, 4:01pm |
|
@Gambiste1 RT @Sandman7591: $CASI breaks over 4 can see the whole formation breaking over 435 January 6th 2020, 12:01pm |
|
@LoncarFunds $CASI Chairman Wei-Wu He talks China biotech https://t.co/kgHrrVz54t https://t.co/hppkdoKYFe January 2nd 2020, 10:01am |
 |
@stocknewstimes BidaskClub Downgrades CASI Pharmaceuticals $CASI to Strong Sell https://t.co/irZO0RbXVB December 29th 2019, 2:12am |
 |
@storminvestor BidaskClub Downgrades CASI Pharmaceuticals $CASI to Strong Sell https://t.co/LQF5nJLfI9 #markets December 29th 2019, 2:12am |
 |
@TheMarketsDaily BidaskClub Downgrades CASI Pharmaceuticals $CASI to Strong Sell https://t.co/HMPmJ5OHm2 December 29th 2019, 2:12am |
 |
@TranscriptDaily CASI Pharmaceuticals $CASI Downgraded by BidaskClub https://t.co/QZNn8GqXhM December 28th 2019, 3:12am |
|
@dailypoliticaln CASI Pharmaceuticals $CASI Cut to “Strong Sell” at BidaskClub https://t.co/t4i2bL6raL December 28th 2019, 3:12am |
 |
@ZolmaxNews CASI Pharmaceuticals $CASI Rating Lowered to Strong Sell at BidaskClub https://t.co/i6TPl0nfe2 December 27th 2019, 2:12am |
|
@EnterpriseLeade CASI Pharmaceuticals $CASI Downgraded by BidaskClub to “Strong Sell” https://t.co/j2mShN1zLc December 27th 2019, 2:12am |
|
@ThisLincolnian CASI Pharmaceuticals $CASI Lowered to “Strong Sell” at BidaskClub https://t.co/ENjfPlQBka December 26th 2019, 5:12am |
|
@WatchlistN CASI Pharmaceuticals $CASI Downgraded to “Strong Sell” at BidaskClub https://t.co/Xgn8NDh3kD December 26th 2019, 5:12am |
 |
@TickerReport CASI Pharmaceuticals $CASI Lowered to “Strong Sell” at BidaskClub https://t.co/FftXG62jFK December 25th 2019, 2:12am |
 |
@InsiderAlertsIA $CASI: New Insider Filing on Chairman and CEO WEI-WU HE: https://t.co/34zpQ6mgAE December 18th 2019, 4:12pm |
 |
@jodietheai Wei Wu He, Chairman and CEO of CASI PHARMACEUTICALS, INC. - $CASI increased their shareholding by 7% to now own a t… https://t.co/amaaDY0Qnp December 18th 2019, 4:12pm |
|
@InsiderAlertsIA $CASI: New Insider Filing on Chief Medical Officer ALEXANDER A ZUKIWSKI: https://t.co/DMO6D4c5Lw December 17th 2019, 4:12pm |
|
@ResearchPool $CASI #CASI Pharmaceuticals CASI Pharmaceuticals - Evomela shows a strong launch: CASI announced earnings for Q319… https://t.co/GAHR8AdQfW December 16th 2019, 7:12am |
 |
@WeekHerald CASI Pharmaceuticals Inc $CASI Short Interest Down 13.8% in November https://t.co/2jPhJRTN2h December 12th 2019, 5:12pm |
|
@OlympiaReport CASI Pharmaceuticals Inc $CASI Short Interest Down 13.8% in November https://t.co/TRGRL1a9Lf December 12th 2019, 5:12pm |
|
@AmericanBanking CASI Pharmaceuticals Inc $CASI Short Interest Down 13.8% in November https://t.co/1hEs15MEwv #stocks December 12th 2019, 5:12pm |
|
@TranscriptDaily CASI Pharmaceuticals $CASI Shares Cross Above Two Hundred Day Moving Average of $3.21 https://t.co/VJtRDAqIbI December 9th 2019, 7:12pm |
 |
@1stOncology #CASIPharmaceuticals Announces China #NMPA Approval Of #CNCT19 (#CD19 #CART) Clinical Trial Applications $CASI https://t.co/HXa3pCF5EV December 4th 2019, 7:12am |
|
@Gambiste1 RT @otcdynamics: $CASI CASI Pharmaceuticals Announces China NMPA Approval Of CNCT19 (CD19 CAR-T) Clinical Trial Applications https://t.co/m… December 3rd 2019, 10:12pm |
|
@Gambiste1 RT @newsfilterio: CASI Pharmaceuticals Announces China NMPA Approval Of CNCT19 (CD19 CAR-T) Clinical Trial Applications $CASI https://t.co/… December 3rd 2019, 10:12pm |
 |
@otcdynamics $CASI CASI Pharmaceuticals Announces China NMPA Approval Of CNCT19 (CD19 CAR-T) Clinical Trial Applications https://t.co/mbQTGu9IsH December 3rd 2019, 9:12pm |
 |
@newsfilterio CASI Pharmaceuticals Announces China NMPA Approval Of CNCT19 (CD19 CAR-T) Clinical Trial Applications $CASI https://t.co/YlCcd3sCIN December 3rd 2019, 9:12pm |
 |
@dakotafinancial Amgen $AMGN and CASI Pharmaceuticals $CASI Head to Head Contrast https://t.co/mg1WFZqRMX December 3rd 2019, 1:12am |
 |
@intercooleronli CASI Pharmaceuticals $CASI Stock Passes Above Two Hundred Day Moving Average of $3.21 https://t.co/oa2c5fLtXt #investingnews November 30th 2019, 7:11am |
 |
@ledgerzette CASI Pharmaceuticals $CASI Stock Passes Above Two Hundred Day Moving Average of $3.21 https://t.co/tPvPdCuzO6 #stocks November 30th 2019, 7:11am |
|
@AmericanBanking CASI Pharmaceuticals $CASI and Amgen $AMGN Head to Head Comparison https://t.co/j2XlBUBLtc #stocks November 30th 2019, 2:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.